Mariner’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Mariner’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-39,997	Closed	-$2K	–	3891
2026 Q1	$2K	Sell	39,997 -3	-0%	–	﹤0.01%	3539
2025 Q4	$2.51K	Buy	+40,000	New	+$1.96K	﹤0.01%	3521

Other funds holding SXTPW

Walleye Capital New York $28B AUM 44.22% 1-Year Est. Return

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $3.47B AUM 37.88% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Mariner's SXTPW Position: Q2 2026 in Review

Mariner sold out of 60 Degrees Pharmaceuticals Warrant (SXTPW) in Q2 2026, closing a stake of 39,997 shares — an estimated $2K sold.

Mariner first reported a position in SXTPW in Q4 2025 and held it in 2 quarters. The position peaked at $2.51K in Q4 2025. 5 funds tracked by Wall St. Rank hold SXTPW as of Q2 2026.

Mariner reported no remaining 60 Degrees Pharmaceuticals Warrant position as of Q2 2026 after selling out during the quarter.
Mariner sold 39,997 60 Degrees Pharmaceuticals Warrant shares in Q2 2026, an estimated $2K.
Mariner first reported a position in 60 Degrees Pharmaceuticals Warrant in Q4 2025 and held it in 2 quarters.
Mariner's 60 Degrees Pharmaceuticals Warrant position peaked at $2.51K in Q4 2025.
5 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q2 2026.

Based on Mariner's 13F filing for Q2 2026, filed 13 Aug 2026.